A phase 3, multicenter, randomized controlled trial of panitumumab plus best supportive care (BSC) vs. BSC alone in patients with metastatic colorectal cancer. - Peeters,M.; Van Cutsem,E.; Siena,S.; Humblet,Y.; Hendlisz,A.; Neyns,J.; Canon,J.; Van Laethem,M.; Amado,R. (Proc Am Soc Clin Oncol, 2006)